Three companies of the Ulm BioRegion have recently announced successful achievements: Boehringer Ingelheim announced that the European Commission has given the full marketing authorisation for an anti-AIDS drug; ratiopharm announced the signing of discount agreements with ten public health insurance companies (AOK) and the Hartmann Group reported the acquisition of Kneipp.
The Ulm producer of generic drugs, ratiopharm, has signed discount agreements for over 1,450 drugs in almost all fields of medication with ten German public health insurance companies. According to information from the company, these companies are located in Baden-Württemberg, Bavaria, Berlin, Mecklenburg-Western Pomerania, Lower Saxony, Rhineland-Palatinate, Saarland, Saxony-Anhalt, Saxony/Thuringia and Westphalia-Lippe. The agreements benefit almost 20 million insured people. According to the company, 950 of the discounted drugs are fully recompensed by the insurance companies. The agreements will come into effect immediately. The agreements signed between ratiopharm and all German AOKs in January 2008 remain valid.